Discover how CIOs can leverage AI to modernize legacy programming languages, reduce technical debt, and enhance operational ...

Florida's Python Elimination Program pays certified hunters to remove the invasive snakes from the Everglades. Burmese pythons have caused a severe decline in native small mammal populations in South ...

The FBI warns of rising ATM jackpotting attacks, where hackers use malware to force ATM machines to dispense cash without ...

Strategy expanded its ability to raise capital via at‑the‑market equity and preferred offerings, adding new agents and ...

Strategy sold a record amount of STRC, estimated to fund 1,420 Bitcoin purchases in a single day after easing ATM sales restrictions. Michael Saylor’s Strategy, the world’s largest public holder of ...

IREN Limited is aggressively expanding AI cloud capacity, targeting 150,000 GPUs and $3.7 billion annualized run-rate revenue by 2026. IREN's vertically integrated model offers operational flexibility ...

Vancouver, British Columbia and Johannesburg, South Africa--(Newsfile Corp. - March 10, 2026) - Platinum Group Metals Ltd. (PLG) ("Platinum Group" or the "Company") reports that it has entered into a ...

Bitcoin miner-turned-AI cloud operator IREN (NASDAQ:IREN) shocked investors this week with a stunning announcement: it expanded its at-the-market (ATM) equity offering program to a whopping $6 billion ...

IREN is financing its AI data-center expansion through a massive equity offering that raises dilution concerns similar to AMC’s repeated share issuances during the meme-stock era. Are you ahead, or ...

Soluna (SLNH) filed a registration statement late Monday with the US Securities and Exchange Commission for the potential sale of up to $1 billion of securities from time to time. The filing covers ...

Robin Energy Ltd. (NASDAQ:RBNE) said Wednesday it has generated $13.9 million in gross proceeds through its at-the-market (ATM) share issuance program since the start of the first quarter of 2026. The ...

Phase 3 trial of once-weekly canvuparatide remains on track to initiate in Q3 2026 following recently completed, successful End-of-Phase 2 meeting with FDA 12-week MAD Phase 1 data from MBX 4291 for ...